logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Goldline Pharmaceutical Share Price

Goldline Pharmaceutical Ltd.

51.25

-2.69(-4.99%)
21st May 2026 | 12:14 PM
NSE :
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Goldline Pharmaceutical Performance

Price Movement

N/A

₹51.25

₹51.25

Today's LowToday's High

1 Year Performance

Data is not available

Markets Today

High₹51.25
Low₹51.25
Open at₹51.25
Prev Close₹53.94
Volumes27.00 K
Avg Price₹51.25
Lower Circuit₹51.25
Upper Circuit₹56.63

Historical Performance

3M High₹60.00
3M Low₹53.94
1 Yr High₹60.00
1 Yr Low₹53.94
3 Yr High₹60.00
3 Yr Low₹53.94
5 Yr High₹60.00
5 Yr Low₹53.94

Goldline Pharmaceutical Fundamentals

Market Cap
Low in industry
51.80 Cr.
PE Ratio (TTM)
Below industry Median
18.30
Dividend Yield
0
Net Profit TTM
Net profit TTM
-
Net Profit Growth
Net profit TTM
-
PEG Ratio
-
ROE
11.3% incr over last year
33.15
Operating Revenue TTM
-
Operating Revenue Growth
Operating Revenue TTM
Book Value
Above industry Median
3.90
MFI
MFI is not available
-
RSI
RSI is not available
-
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
3.90

Goldline Pharmaceutical Financials

Data not available for chart

Indicator
No Record Found

Goldline Pharmaceutical Technicals

Goldline Pharmaceutical Ltd. EMA & SMA

51.25

-5.52 (-9.72%)

Bullish Moving Average

0

Bearish Moving Average

0

-
-
-
-
-
-
-
-

Goldline Pharmaceutical Support and Resistance

Resistance

First Resistance₹53.94
Second Resistance₹53.94
Third Resistance₹53.94

Support

First Support₹53.94
Second Support₹53.94
Third Support₹53.94

Technical Indicators

Day RSI-
Day MFI-
Day ADX-
Day Commodity Channel Index-
William-
Day MACD-
Day MACD Signal Line-
Day ATR-
Day ROC125-
Day ROC21-

Goldline Pharmaceutical Shareholding Pattern

Held By
Promoter
FII
DII
Public

Goldline Pharmaceutical Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day10.17 L10.17 L100.00%
Week00undefined%
1 Month00undefined%
6 Month8.4 K8.4 K100.00%

Goldline Pharmaceutical SWOT Analysis

Strengths6
Weakness4
Opportunity0
Threats0

Annual Profit Growth higher than Sector Profit Growth

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with reducing Debt

Annual Net Profits improving for last 2 years

Goldline Pharmaceutical Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
No Record Found

Goldline Pharmaceutical Stock Comparison

Financials
Price (₹)₹482₹219.90₹263₹34.99₹6.47
% Change0.28%-4.99%0.00%-0.28%-0.61%
Revenue TTM (₹ Cr)---₹0.54₹83.60
Net Profit TTM (₹ Cr)---₹-0.24₹-34.95
PE TTM-23.6037.60-89.20-1.50
1 Year Return22.61679.78551
ROCE28.91----5.63

FAQ's on GLPL

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy